People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VeraDermics, Inc | — | Other Health Care | Series D+ | $239.3M | $1.0B | 2021 |
Jane W. Grant-Kels at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jane W. Grant-Kels on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Enright | 1 | 10 |
| John W. Childs | 1 | 4 |
| John Childs | 1 | 3 |
| Vladimir Coric | 1 | 2 |
| Reid Waldman | 1 | 1 |
| Reid W. Waldman | 1 | 1 |
| Amanda W. Birdsey-Benson | 1 | 1 |
| Christopher W. Eklund | 1 | 1 |
| Vladimir W. Coric | 1 | 1 |
| Patrick W. Enright | 1 | 1 |
| Timothy Durso | 1 | 1 |
| Katarina Pance | 1 | 1 |
| Amanda Birdsey-Benson | 1 | 1 |
| Jane Grant-Kels | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.